Effect of androgen deprivation therapy on cognitive functioning in men with prostate cancer: A systematic review
- PMID: 34128263
- PMCID: PMC9545697
- DOI: 10.1111/iju.14596
Effect of androgen deprivation therapy on cognitive functioning in men with prostate cancer: A systematic review
Abstract
The objective of this study was to review publications assessing cognitive functioning in patients with prostate cancer treated with androgen deprivation therapy. We conducted a systematic review of the literature published in PubMed, Embase, Web of Science, Cochrane Library, and PsycINFO up to February 2020. A total of 31 studies were included. Half of the studies (n = 16) demonstrated that androgen deprivation therapy in patients with prostate carcinoma did not result in a negative effect on cognitive functioning, however, still a substantial proportion of the studies (n = 11) reported a negative effect on cognitive functioning. In four studies the results were inconclusive. In the three studies using additional functional magnetic resonance imaging, no significant effect on neuropsychological tests was found, but grey matter volume, brain activity, and brain connectivity were affected. Given the substantial number of studies showing a significant negative effect of androgen deprivation therapy on cognitive functioning, clinicians should be aware of this side effect. Furthermore, future research should focus on the further examination of brain characteristics using functional magnetic resonance imaging, since these techniques might be more sensitive in detecting brain abnormalities as a result of androgen deprivation therapy.
Keywords: androgen deprivation therapy; cognitive functioning.
© 2021 The Authors. International Journal of Urology published by John Wiley & Sons Australia, Ltd on behalf of the Japanese Urological Association.
Conflict of interest statement
None declared.
Figures
Similar articles
-
Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer.Cochrane Database Syst Rev. 2006 Oct 18;2006(4):CD006019. doi: 10.1002/14651858.CD006019.pub2. Cochrane Database Syst Rev. 2006. PMID: 17054269 Free PMC article.
-
Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.Cochrane Database Syst Rev. 2002;(1):CD003506. doi: 10.1002/14651858.CD003506. Cochrane Database Syst Rev. 2002. Update in: Cochrane Database Syst Rev. 2019 Jun 11;6:CD003506. doi: 10.1002/14651858.CD003506.pub2. PMID: 11869665 Updated.
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
Cognitive functioning in men receiving androgen deprivation therapy for prostate cancer: a systematic review and meta-analysis.Support Care Cancer. 2014 Aug;22(8):2271-80. doi: 10.1007/s00520-014-2285-1. Epub 2014 May 25. Support Care Cancer. 2014. PMID: 24859915 Free PMC article.
-
Sertindole for schizophrenia.Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2. Cochrane Database Syst Rev. 2005. PMID: 16034864 Free PMC article.
Cited by
-
Identification of distinct symptom profiles in prostate cancer patients with cancer-related cognitive impairment undergoing androgen deprivation therapy: A latent class analysis.Asia Pac J Oncol Nurs. 2024 Apr 27;11(6):100497. doi: 10.1016/j.apjon.2024.100497. eCollection 2024 Jun. Asia Pac J Oncol Nurs. 2024. PMID: 38845748 Free PMC article.
-
Cognitive outcomes in prostate cancer treatment: insights from the ODENZA trial and future considerations.Transl Androl Urol. 2025 Apr 30;14(4):864-867. doi: 10.21037/tau-2024-747. Epub 2025 Apr 15. Transl Androl Urol. 2025. PMID: 40376525 Free PMC article. No abstract available.
-
Impact of androgen deprivation therapy on cognitive function in men with prostate cancer.BJUI Compass. 2023 Dec 11;5(3):356-358. doi: 10.1002/bco2.319. eCollection 2024 Mar. BJUI Compass. 2023. PMID: 38481674 Free PMC article. No abstract available.
-
Unleashing novel horizons in advanced prostate cancer treatment: investigating the potential of prostate specific membrane antigen-targeted nanomedicine-based combination therapy.Front Immunol. 2023 Sep 19;14:1265751. doi: 10.3389/fimmu.2023.1265751. eCollection 2023. Front Immunol. 2023. PMID: 37795091 Free PMC article. Review.
-
Impact of Androgen Deprivation Therapy on Cognitive Function of Elderly Men With Prostate Cancer.Cureus. 2024 Sep 12;16(9):e69303. doi: 10.7759/cureus.69303. eCollection 2024 Sep. Cureus. 2024. PMID: 39398693 Free PMC article.
References
-
- World Cancer Research Fund. Prostate cancer statistics. [Cited 3 May 2021.] Available from URL: https://www.wcrf.org/dietandcancer/prostate‐cancer‐statistics/
-
- Crawford ED, Schally AV, Pinthus JH et al. The potential role of follicle‐stimulating hormone in the cardiovascular, metabolic, skeletal, and cognitive effects associated with androgen deprivation therapy. Urol. Oncol. 2017; 35: 183–91. - PubMed
-
- Nguyen C, Lairson DR, Swartz MD, Du XL. Risks of major long‐term side effects associated with androgen‐deprivation therapy in men with prostate cancer. Pharmacotherapy 2018; 38: 999–1009. - PubMed
-
- Salminen EK, Portin RI, Koskinen A, Helenius H, Nurmi M. Associations between serum testosterone fall and cognitive function in prostate cancer patients. Clin. Cancer Res. 2004; 10: 7575–82. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical